Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges

Bashdar Mahmud Hussen; Mohammed Fatih Rasul; Snur Rasool Abdullah; Hazha Jamal Hidayat; Goran Sedeeq Hama Faraj; Fattma Abodi Ali; Abbas Salihi; Aria Baniahmad; Soudeh Ghafouri-Fard; Milladur Rahman; Mark C. Glassy; Wojciech Branicki; Mohammad Taheri

doi:10.1186/s40779-023-00468-6

Your Location：

Home >

Browse articles >

Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges

REVIEW | Updated：2025-12-13

Previous|Next

- Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges
- Bashdar Mahmud Hussen , Mohammed Fatih Rasul , Snur Rasool Abdullah , Hazha Jamal Hidayat , Goran Sedeeq Hama Faraj , Fattma Abodi Ali , Abbas Salihi , Aria Baniahmad , Soudeh Ghafouri-Fard , Milladur Rahman , Mark C. Glassy , Wojciech Branicki , Mohammad Taheri
- Military Medical Research Vol. 11, Issue 3, Pages: 345-373(2024)
- Affiliations：
  1.Department of Biomedical Sciences, Cihan University-Erbil, Erbil, Kurdistan Region 44001, Iraq
  2.Department of Clinical Analysis, College of Pharmacy, Hawler Medical University, Erbil, Kurdistan Region 44001, Iraq
  3.Department of Pharmaceutical Basic Science, Faculty of Pharmacy, Tishk International University, Erbil, Kurdistan Region 44001, Iraq
  4.Medical Laboratory Science, Lebanese French University, Erbil, Kurdistan Region 44001, Iraq
  5.Department of Biology, College of Education, Salahaddin University-Erbil, Erbil, Kurdistan Region 44001, Iraq
  6.Department of Medical Laboratory Science, Komar University of Science and Technology, Sulaymaniyah 46001, Iraq
  7.Department of Medical Microbiology, College of Health Sciences, Hawler Medical University, Erbil, Kurdistan Region 44001, Iraq
  8.Department of Biology, College of Science, Salahaddin University-Erbil, Erbil, Kurdistan Region 44001, Iraq
  9.Center of Research and Strategic Studies, Lebanese French University, Erbil 44001, Iraq
  10.Institute of Human Genetics, Jena University Hospital, 07747 Jena, Germany
  11.Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran 374-37515, Iran
  12.Department of Clinical Sciences, Malmö, Section for Surgery, Lund University, 22100 Malmö, Sweden
  13.Translational Neuro-Oncology Laboratory, San Diego (UCSD) Moores Cancer Center, University of California, San Diego, CA 94720, USA
  14.Faculty of Biology, Institute of Zoology and Biomedical Research, Jagiellonian University, 31-007 Kraków, Poland
  15.Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran 374-37515, Iran
- Author bio：
  *wojciech.branicki@uj.edu.pl;
  mohammad.taheri@uni-jena.de
- Funds：
- DOI： 10.1186/s40779-023-00468-6
  CLC：
- Accepted：
Scan QR Code
DOI：
DOI：

Full Text(HTML)
Figs( 8 ) Tabs( 6 )
References
Publication Info
Metrics

摘要

Abstract

关键词

Keywords

references

31

Views

21

Downloads

0

CSCD

Alert me when the article has been cited

Submit

Tools

BibTeXDownload
EndnoteDownload
RefMan Download
NoteExpressDownload
NoteFirstDownload

Publicity Resources

Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges

DOI： 10.1186/s40779-023-00468-6

Full Text(HTML)

Figs( 8 ) Tabs( 6 )

References

Publication Info

Metrics

摘要

Abstract

关键词

Keywords

references